HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection [Phase 2]
A Phase 2 trial evaluated glecaprevir/pibrentasvir fixed-dose combination for acute hepatitis C infection, with the study completed and resu…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: ANCHORS Study: UH2 Project [NA]
The ANCHORS study UH2 project for HIV-1 infection has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients
Real-life study evaluating dolutegravir plus lamivudine in treatment-naive adults with HIV-1 infection. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine [NA]
A completed clinical trial evaluating the integration of addiction treatment and HIV services into primary care clinics in Ukraine, sponsore…
-
CLINICAL_TRIALS other · 2024-07-09Clinical Trial Update: Triage Survey for Infectious Disease Eligibility
A triage survey is being conducted to determine eligibility for an infectious disease study, with HIV-1 infection as a focus and ongoing rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Implementing Long-Acting Novel Antiretrovirals
A completed clinical trial evaluating long-acting novel antiretroviral therapies for HIV treatment has been reported.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008 [Phase 1]
Phase 1 relative bioavailability study of dapivirine vaginal ring candidates Ring-004 and Ring-008 has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Couples ART Adherence Intervention for PWID in Kazakhstan [NA]
This clinical trial update reports the completion and posting of results for a couples-based ART adherence intervention among people who inj…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Unlimited Transportation Passes for Unstable Housed People Living With HIV Trial [NA]
A clinical trial update for a study evaluating unlimited transportation passes to assist unstably housed people living with HIV in engaging …
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating salvage strategy options for post-injectable cabotegravir in HIV pre…
-
CLINICAL_TRIALS withdrawal · 2024-07-03Clinical Trial Update: Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange [NA]
This clinical trial update notes that the Teleneuropsychological Intervention trial (N&C NeuroChange) in asymptomatic HIV-seropositive indiv…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED) [Phase 4]
Phase 4 trial evaluating a simplified model to improve linkage to care and retention among people living with HIV using a mobile unit and sa…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Improving Care and Community Representation for Adolescents and Young Adults Living With HIV in West Africa
A clinical trial update describing ongoing research to improve care and community representation for adolescents and young adults living wit…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: NT-I7 for Kaposi Sarcoma in Patients With or Without HIV [Phase 1]
A Phase 1 trial of NT-I7 for AIDS-related Kaposi sarcoma in patients with or without HIV was terminated; results were posted on 2024-06-27.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System [NA]
Completed clinical trial assessing an electronic home-care system for initiating and maintaining HIV pre-exposure prophylaxis (PrEP) has pos…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Task Shifting to Treat Depression and HIV Medication Nonadherence in Low Resource Settings [NA]
This clinical trial from King's College London is investigating task-shifting strategies to treat depression and improve HIV medication adhe…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Plan and Pledge, HIV Self-testing in South Africa [NA]
A completed trial in South Africa evaluating HIV self-testing (Plan and Pledge) with results posted in June 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV [NA]
A completed clinical trial evaluating the impact of COVID-19 on cardiovascular disease self-management and prevention care in adults living …
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: AURORA Study-A Transformative Approach to Support PrEP Medication Persistence
The AURORA study is a clinical trial aimed at improving persistence with PrEP for HIV prevention and is currently in the recruiting phase.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Durvalumab in HIV-1 Patients With Solid Tumors [Phase 2]
Phase 2 study evaluating durvalumab in HIV-1 infected patients with solid tumors has completed; results have been posted.
-
FDA approval · 2024-06-21FDA Approved: ATAZANAVIR SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for atazanavir sulfate from Aurobindo Pharma Limited, effectively approving this generic HIV proteas…
-
FDA approval · 2024-06-21FDA Approved: ATAZANAVIR — Supplemental Application (Laurus Labs Limited)
FDA approved a supplemental application for atazanavir submitted by Laurus Labs Limited (ANDA 212579).
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa [Phase 3]
Phase 3 trial update evaluating acceptability and feasibility of injectable cabotegravir PrEP versus oral PrEP in routine care at private ph…
-
FDA approval · 2024-06-20FDA Approved: EFAVIRENZ — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for efavirenz from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) [NA]
A clinical trial update indicates the TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM) is currently recruiting. It…